Chemo Pharma Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹31.35
- Today's High:
- ₹34
- Open Price:
- ₹33.05
- 52W Low:
- ₹27.17
- 52W High:
- ₹49.1
- Prev. Close:
- ₹33
- Volume:
- 100
Company Statistics
- Market Cap.:
- ₹30.23 million
- Book Value:
- 72.356
- Revenue TTM:
- ₹7.35 million
- Operating Margin TTM:
- 50.15%
- Gross Profit TTM:
- ₹9.95 million
- Profit Margin:
- 36.83%
- Return on Assets TTM:
- 2.11%
- Return on Equity TTM:
- 0%
Company Profile
Chemo Pharma Laboratories Limited had its IPO on under the ticker symbol 506365.
The company operates in the Other sector and Other industry. Chemo Pharma Laboratories Limited has a staff strength of 0 employees.
Stock update
Shares of Chemo Pharma Laboratories Limited opened at ₹33.05 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹31.35 - ₹34, and closed at ₹31.35.
This is a -5% slip from the previous day's closing price.
A total volume of 100 shares were traded at the close of the day’s session.
In the last one week, shares of Chemo Pharma Laboratories Limited have slipped by -14.6%.
Chemo Pharma Laboratories Limited's Key Ratios
Chemo Pharma Laboratories Limited has a market cap of ₹30.23 million, indicating a price to book ratio of 0.2127 and a price to sales ratio of 0.
In the last 12-months Chemo Pharma Laboratories Limited’s revenue was ₹7.35 million with a gross profit of ₹9.95 million and an EBITDA of ₹4.01 million. The EBITDA ratio measures Chemo Pharma Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Chemo Pharma Laboratories Limited’s operating margin was 50.15% while its return on assets stood at 2.11% with a return of equity of 0%.
In Q3, Chemo Pharma Laboratories Limited’s quarterly earnings growth was a negative -43.7% while revenue growth was a negative 48.6%.
Chemo Pharma Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 8.5635
- PEG
Its diluted EPS in the last 12-months stands at ₹1.806 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Chemo Pharma Laboratories Limited’s profitability.
Chemo Pharma Laboratories Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Chemo Pharma Laboratories Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹111.28 million
- Total Liabilities
- ₹1.99 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Chemo Pharma Laboratories Limited ended 2024 with ₹111.28 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹111.28 million while shareholder equity stood at ₹109.29 million.
Chemo Pharma Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.99 million in other current liabilities, 15000000.00 in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹87.27 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Chemo Pharma Laboratories Limited’s total current assets stands at ₹90.71 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹3.44 million compared to accounts payable of ₹0 and inventory worth ₹0.
In 2024, Chemo Pharma Laboratories Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Chemo Pharma Laboratories Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹31.35
- 52-Week High
- ₹49.1
- 52-Week Low
- ₹27.17
- Analyst Target Price
- ₹
Chemo Pharma Laboratories Limited stock is currently trading at ₹31.35 per share. It touched a 52-week high of ₹49.1 and a 52-week low of ₹49.1. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹33.75 and 200-day moving average was ₹37.27 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 3701.3% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Chemo Pharma Laboratories Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Chemo Pharma Laboratories Limited does not have significant operations. Previously, it was engaged in the finance and investment activities. The company was founded in 1942 and is based in Mumbai, India.